文献速递毛发、甲与色素性疾病

自体非培养黑素细胞-角质形成细胞移植长期随访:白癜风及其他白斑病的复色持久性

Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas.
PubMed 文献 · J Am Acad Dermatol · 2017-05-11

该研究回顾性分析了2009年1月至2014年4月在Henry Ford医院接受黑素细胞-角质形成细胞移植(MKTP)的患者,评估白癜风及其他白斑病的长期复色情况。结果显示,节段性白癜风、非节段性白癜风和物理性白斑病的VASI评分分别改善-75.6±24.6%、-59.2±36.6%和-32.4±33.5%;白癜风患者在术后24、48、72个月分别有53%、64%、53%的解剖学病灶维持>75%复色。结论认为MKTP在多数经适当选择的患者中可提供满意的长期复色,并至少维持72个月。

要点

  • MKTP可使节段性白癜风VASI评分改善-75.6±24.6%。
  • 白癜风患者在24、48、72个月分别有53%、64%、53%的病灶维持>75%复色。
  • 皮肤光型、年龄和病灶解剖部位对治疗结果无显著影响。

核心结论

  • MKTP在多数经适当选择的患者中可提供满意的长期复色。
  • MKTP可维持复色至少72个月。

研究设计与样本

  • 回顾性电子病历审查,纳入2009年1月至2014年4月在Henry Ford医院接受MKTP的全部患者。

主要发现

  • 节段性白癜风VASI评分改善-75.6±24.6%。
  • 非节段性白癜风VASI评分改善-59.2±36.6%。
  • 物理性白斑病VASI评分改善-32.4±33.5%。
  • 白癜风患者在MKTP术后24、48、72个月分别有53%、64%、53%的解剖学病灶维持>75%复色。
  • 皮肤光型、年龄和病灶解剖部位对治疗结果无显著影响。

局限性

  • 研究为回顾性设计,术后辅助治疗未受控制,且对计划随访评估的依从性不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Persistence of pigmentation after a melanocyte-keratinocyte transplantation procedure (MKTP) is an important consideration for efficacy. OBJECTIVE: We sought to determine long-term repigmentation of MKTP in vitiligo and other leukodermas. METHODS: A retrospective review of electronic medical records was conducted for all MKTPs performed at Henry Ford Hospital between January 2009 and April 2014. Repigmentation was assessed by a 5-point grading scale (poor to excellent) and Vitiligo Area Scoring Index (VASI). RESULTS: One hundred patients had MKTP performed at 236 anatomically-based lesions (ABLs); 63 patients with 157 ABLs had long-term data available (12-72 months; median, 24 months). Segmental vitiligo, nonsegmental vitiligo, and physical leukoderma demonstrated improvement in VASI scores: -75.6 ± 24.6%, -59.2 ± 36.6%, and -32.4 ± 33.5%, respectively. In vitiligo, at 24, 48, and 72 months after MKTP, 53%, 64%, and 53% of ABLs, respectively, maintained >75% repigmentation. Skin phototype, age, and anatomic location of ABLs had no significant effect on the outcome of treatment. LIMITATIONS: Limitations of the study include the retrospective design with uncontrolled, postoperative adjuvant treatments and inconsistent compliance to scheduled follow-up evaluations. CONCLUSIONS: MKTP provides satisfactory long-term repigmentation in the majority of appropriately selected patients with leukoderma. MKTP can maintain repigmentation for at least 72 months.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Silpa-Archa N, Griffith JL, Huggins RH, et al. Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas. J Am Acad Dermatol. 2017. PMID: 28502377. doi:10.1016/j.jaad.2017.01.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。